XUAB 1769: Phase lb 9cUAB30 In Early Stage Breast Cancer to Evaluate Biologic Effect (Cost Reimbursable)

Grant

Total Award Amount

  • 538334.00
  • Direct Costs

  • 366214.00
  • Sponsor Award Id

  • 769K742
  • Contributor

  • Erica Stringer-Reasor M.D.   Investigator  
  • Helen Krontiras M.D.   Principal Investigator  
  • Jennifer De Los Santos   Investigator